Prospective cohort study showing changes in the monthly incidence of Pneumocystis carinii pneumonia

Postgraduate Medical Journal

Volumn 79, Issue 929, 2003, Pages 164-166

  Lubis, N ^a   Baylis, D ^a   Short, A ^a   Stebbing, Justin ^b   Teague, A ^b   Portsmouth, S ^b   Bower, M ^b   Nelson, M ^b   Gazzard, B ^b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; RAIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CLIMATE; COHORT ANALYSIS; CORRELATION ANALYSIS; DATA BASE; HELPER CELL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION PREVENTION; INFECTION SENSITIVITY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; OPPORTUNISTIC INFECTION; PARASITE TRANSMISSION; PNEUMOCYSTIS PNEUMONIA; PROSPECTIVE STUDY; SEASONAL VARIATION; WINTER;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LONDON; MIDDLE AGED; PNEUMONIA, PNEUMOCYSTIS; PROSPECTIVE STUDIES; SEASONS; TIME FACTORS;

EID: 0242416657     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.79.929.164     Document Type: Article

References (19)

1. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-60.
2. Phair J, Munoz A, Detels R, et al. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group. N Engl J Med 1990;322:161-5.
3. Hughes WT. Current issues in the epidemiology, transmission, and reactivation of Pneumocystis carinii pneumonia. Semin Respir Infect 1998;13:282-8.
4. Eccles R. An explanation for the seasonality of acute upper respiratory tract viral infections. Acta Otolaryngol 2002;122:183-91.
5. Miller RF, Grant AD, Foley NM. Seasonal variation in presentation of Pneumocystis carinii pneumonia. Lancet 1992;339:747-8.
6. Vanhems P, Hirschel B, Morabia A. Seasonal incidence of Pneumocystis carinii pneumonia. Lancet 1992;339:1182.
7. Meteorological Office. Available at: http://www.meto.gov.uk/.
8. Mocroft A, Sabin CA, Youle M, et al. Changes in AIDS-defining illnesses in a London clinic, 1987-98. J Acquir Immune Defic 1999;21:401-7.
9. Barry SM, Johnson MA. Pneumocystis carinii pneumonia: a review of current issues in diagnosis and management. HIV Medicine 2001;2:123-32.
10. Wakefield AE. Pneumocystis carinii. Br Med Bull 2002;61:175-88.
11. Rimland D, Navin TR, Lennox JL, et al. Prospective study of etiologic agents of community-acquired pneumonia in patients with HIV infection. AIDS 2002;16:85-95.
12. Bochud PY, Moser F, Erard P, et al. Community-acquired pneumonia. A prospective outpatient study. Medicine (Baltimore) 2001;80:75-87.
13. Torsvik V, Ovreas L, Thingstad TF. Prokaryofic diversity-magnitude, dynamics and controlling factors. Science 2002;296:1064-6.
14. Birmingham K, Cooney S. Ebola: small but real progress. Nat Med 2002;8:313.
15. Alderson M. Season and mortality. Health Trends 1985;17:87-96.
16. Laakkonen J, Hentonnen H, Niemimaa J, et al. Seasonal dynamics of Pneumocystis carinii in the field vole, Microtus agrestis, and in the common shrew, Sorex araneus, in Finland. Parasitology 1999;11B:1-5.
17. Smulian AG. Pneumocystis carinii: genetic diversity and cell biology. Fungal Genet Biol 2001;34:145-54.
18. Helweg-Larsen J, Benfield TL, Eugen-Olsen J, et al. Effects of mutations in Pneumocysfis carinii dihydropterroate synthase gene on outcome of AIDS-associated P carinii pneumonia. Lancet 1999;354:1347-51.
19. Keely SP, Stringer JR, Baughman RP, et al. Genetic variation among Pneumocystis carinii isolates in recurrent pneumocystis. J Infect Dis 1995;172:595-8.